Updated Jul 16, 2026
ROBERTS EIRY has filed 2 SEC Form 4 filings across 2 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-26 | BHC | Bausch Health Companies Inc. | A — Grant or award | 45.9K | $0.00 | |
| 2026-04-27 | FOLD | AMICUS THERAPEUTICS, INC. | D — Derivative transaction | 76.3K | $14.50 | $1.11M |
| 2025-06-05 | FOLD | AMICUS THERAPEUTICS, INC. | A — Grant or award | 20.4K | $0.00 | |
| 2024-11-12 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 1 | $79.02 | $79 |
| 2024-11-12 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 971 | $102.90 | $100K |
| 2024-11-12 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 1.2K | $81.05 | $100K |
| 2024-11-12 | NBIX | NEUROCRINE BIOSCIENCES INC | M — Option exercise | 5.1K | $77.81 | $400K |
ROBERTS EIRY is a corporate insider — currently tracked as Director of Bausch Health Companies Inc. (BHC). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live ROBERTS EIRY profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.